Over the years, novel biomarkers for HCC have been suggested, such as prothrombin induced by vitamin K absence-II (PIVKA-II, also known as des-gamma-carboxy prothrombin) and lens culinaris agglutinin-reactive fraction of alpha-fetoprotein (AFP-L3%) (13). Here, AFP is linked to hepatocellular carcinoma.